Variable | Total N = 5730 | Consent N = 2378 | Non-consent N = 1907 | Non-response N = 1445 |
---|---|---|---|---|
Age, median (Q1-Q3)a | 67 (54.0–77.0) | 63 (51.0–73.0) | 71 (59.0–80.0) | 66 (54.0–77.0) |
Sex (women), N(%)a | 2828 (49.4) | 1083/2378 (45.5) | 1025/1907 (53.7) | 720/1445 (49.8) |
High education, N(%)b | 579 (19.2) | 357/1724 (20.7) | 153/1001 (15.3) | 69/284 (24.3) |
Current Smoking, N(%)b | 471 (11.9) | 264/2289 (11.5) | 167/1281 (13.0) | 40/372 (10.8) |
Specialist specific OPDa | ||||
 -Cardiology | 2783 (48.6) | 1173/2378 (49.3) | 815/1907 (42.7) | 795/1445 (55.0) |
 -Diabetology | 303 (5.3) | 171/2378 (7.2) | 60/1907 (3.1) | 72/1445 (5.0) |
 -Geriatrics | 1779 (31.0) | 479/2378 (20.1) | 909/1907 (47.7) | 391/1445 (27.1) |
 -Nephrology | 435 (7.6) | 270/2378 (11.4) | 74/1907 (3.9) | 91/1445 (6.3) |
 -Vascular medicine | 430 (7.5) | 285/2378 (12.0) | 49/1907 (2.6) | 96/1445 (6.6) |
Physical Activity per week (METminutes), median(Q1-Q3)b | 4480.0 (2265.0- 7710.0) | 4800 (2550.0–7995.0) | 3675 (1638.8–6840.0) | 5490.0 (2955.0–8026.5) |
Previous AMI, CABG, CHF, Stroke, ICH, TIA, PAD (IC, AAA, Carotid), N(%)b | 1400 (35.3) | 782/2303 (34.0) | 507/1292 (39.2) | 111/372 (29.8) |
Previous AMI, CABG, arrest, N(%)b | 678 (17.1) | 391/2303 (17.0) | 226/1292 (17.5) | 61/372 (16.4) |
Previous CHF, N(%)b | 401 (10.1) | 237/2303 (10.3) | 130/1292 (10.1) | 34/372 (9.1) |
Previous stroke, ICH, TIA, N(%)b | 527 (13.3) | 289/2303 (12.5) | 207/1292 (16.0) | 31/372 (8.3) |
Previous peripheral arterial disease, N(%)b | 364 (9.2) | 196/2303 (8.5) | 141/1292 (10.9) | 27/372 (7.3) |
Hypertension, N(%)b | 1963 (49.5) | 1126/2303 (48.9) | 657/1292 (50.9) | 180/372 (48.4) |
Kidney disease, N(%)b | 755 (19.0) | 470/2303 (20.4) | 230/1292 (17.8) | 55/372 (14.8) |
Proteinuria, N(%)b | 521 (13.1) | 344/2303 (14.9) | 130/1292 (10.1) | 47/372 (12.6) |
Diabetes, N(%)b | 833 (21.0) | 504/2303 (21.9) | 264/1292 (20.4) | 65/372 (17.5) |
Hyperlipidemia, N(%)a | 1555 (43.4) | 858/1945 (44.1) | 588/1362 (43.2) | 109/275 (39.6) |
Body Mass Index (kg/m2), median(Q1-Q3)a | 25.9 (23.1–29.4) | 26.3 (23.5–29.6) | 25.6 (22.9–29.1) | 25.3 (22.6–28.7) |
Heart rate (bpm), mean(SD)a | 74.8 (14.6) | 74.0 (14.1) | 75.1 (14.7) | 76.7 (15.8) |
Systolic blood pressure (mmHg), mean(SD)a | 141.7 (24.1) | 140.7 (22.6) | 145.1 (25.4) | 134.6 (24.2) |
Diastolic blood pressure (mmHg), mean(SD)a | 80.0 (12.4) | 80.8 (12.0) | 80.3 (12.3) | 75.4 (13.5) |
Total Cholesterol (mmol/L), median(Q1-Q3)a | 5.1 (4.2–6.0) | 5.1 (4.3–6.0) | 5.1 (4.2–6.0) | 4.8 (3.9–5.8) |
HDL-Cholesterol (mmol/L), median(Q1-Q3)a | 1.3 (1.1–1.6) | 1.3 (1.1–1.6) | 1.3 (1.1–1.6) | 1.2 (1.0–1.5) |
Hb (mmol/L), mean(SD)a | 8.6 (1.1) | 8.8 (1.0) | 8.5 (1.1) | 8.1 (1.3) |
Creatinine (μmol/L), median(Q1-Q3)a | 76.0 (64.0–95.0) | 76 (65.0–93.0) | 75 (63.0–94.0) | 79 (65.0–102.8) |
eGFR (CKD epi), mean(SD)a | 77.5 (25.9) | 80.1 (24.9) | 75.7 (25.5) | 73.7 (28.6) |
HbA1c (mmol/mol), median(Q1-Q3)a | 38.0 (35.0–44.0) | 38 (35.0–43.0) | 38 (35.0–44.0) | 41 (36.0–52.0) |
10-yr risk on CVD, median(Q1-Q3)c | 10.0 (3.0–28.0) | 9.0 (3.0–24.6) | 12.7 (4.0–29.9) | 8.0 (5.0–18.5) |